Your browser doesn't support javascript.
loading
Does Surgical Margin Width Remain a Challenge for Triple-Negative Breast Cancer? A Retrospective Analysis.
Bonci, Eduard-Alexandru; Țîțu, Ștefan; Petrușan, Alexandru Marius; Hossu, Claudiu; Gâta, Vlad Alexandru; Ghomi, Morvarid Talaeian; Kubelac, Paul Milan; Bonci, Teodora Irina; Piciu, Andra; Cosnarovici, Maria; Hîțu, Liviu; Kirsch-Mangu, Alexandra Timea; Pop, Diana Cristina; Lisencu, Ioan Cosmin; Achimaș-Cadariu, Patriciu; Piciu, Doina; Schmidt, Hank; Fetica, Bogdan.
Afiliación
  • Bonci EA; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Țîțu Ș; Department of Surgical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Petrușan AM; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Hossu C; Department of Surgical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Gâta VA; Department of Surgical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Ghomi MT; Department of Surgical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Kubelac PM; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Bonci TI; Department of Surgical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Piciu A; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Cosnarovici M; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Hîțu L; Department of Medical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Kirsch-Mangu AT; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Pop DC; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Lisencu IC; Department of Medical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Achimaș-Cadariu P; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Piciu D; Department of Medical Oncology, "Prof. Dr. Ion Chiricuța" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Schmidt H; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Fetica B; 11th Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Medicina (Kaunas) ; 57(3)2021 Feb 26.
Article en En | MEDLINE | ID: mdl-33652670
ABSTRACT
Background and

Objectives:

Local and distant relapse (LR, DR) in breast cancer vary according to its molecular subtypes, with triple-negative breast cancer (TNBC) being the most aggressive. The surgical resection margin width (SRMW) for breast-conserving surgery (BCS) has been intensely debated, especially for the aforementioned subtype. The aim of this study was to examine the impact of SRMW on LR following BCS in TNBC patients. Materials and

Methods:

We conducted a retrospective study including all patients with TNBC for whom BCS was performed between 2005 and 2014.

Results:

Final analysis included a total of 92 patients, with a median tumor size of 2.5 cm (range 0-5 cm) and no distant metastasis at the time of diagnosis. A total of 87 patients had received neoadjuvant and/or adjuvant chemotherapy, and all patients had received adjuvant whole-breast radiotherapy. After a median follow-up of 110.7 months (95% CI, 95.23-126.166), there were 5 local recurrences and 8 regional/distant recurrences with an overall LR rate of 5.4%. The risk of LR and DR was similar between groups of patients with several SRMW cut-off values.

Conclusions:

Our study supports a safe "no ink on tumor" approach for TNBC patients treated with BCS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Rumanía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Rumanía